Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules
15. Januar 2015 10:46 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg...
Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine
24. März 2014 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that on March 21, 2014, the Company filed a Changes Being...
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
18. Februar 2014 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today successful results from a pilot bioequivalence study...